Laser zapping may help older women get pregnant with frozen embryos
NCT ID NCT07490561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether using a laser to thin the outer shell of a frozen embryo (called laser-assisted hatching) can help women aged 35 and older have a baby. About 916 women will be randomly assigned to receive the laser treatment or standard care. The main goal is to see if the laser improves the chance of a live birth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 916 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
35 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1: Female age ≥ 35 years * 2: First or second vitrified-warmed embryo transfer cycle * 3: Quality of embryos for transfer meeting the criteria: Grade I, II, CP or above (cleavage-stage embryos); Grade 4BC/CB or above (blastocysts) * 4: Provide written informed consent Exclusion Criteria: * 1: Use of donor oocytes or sperm, or planned preimplantation genetic testing (PGT) * 2: Severe immune or chromosomal abnormalities * 3: Uterine cavity abnormalities (i.e., adenomyosis, submucous uterine fibroids, hydrosalpinx, uterine septum, and endometrial polyps) * 4: Embryos with an abnormal zona pellucida * 5: Complicated with severe underlying diseases (e.g., uncontrolled hypertension/diabetes mellitus, active malignant tumors) * 6: A history of recurrent implantation failure (≥2 cycles) or recurrent miscarriage (≥2 episodes)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced age are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.